Personalis is a leading provider of clinical-grade precision genomics information to researchers, clinicians, pharmaceutical companies and the US Department of Veteran Affairs (VA), using its advanced capabilities in the generation and interpretation of sequencing data to analyse whole genomes, exomes and transcriptomes. The company is focused on the application of its ACE ImmunoID™ platform in immuno-oncology and on whole-genome sequencing for the VA’s Million Veterans Program. In connection with the latter, Personalis was recently awarded a contract by the VA to sequence >34,000 whole human genomes, one of the largest such projects anywhere in the world. The company’s CEO, John West, was formerly CEO of the next-generation sequencing (NGS) company, Solexa (a former Abingworth portfolio company), which was acquired by Illumina in 2007 and became the basis for Illumina’s NGS product line.

LocationMenlo Park, California
CEOJohn West
PartnerVincent Miles